Skip to product information
1 of 3

Alpha Synuclein Recombinant Mouse mAb (S-6514)

Alpha Synuclein Recombinant Mouse mAb (S-6514)

Catalog Number: S0B60810 Application: IHC-P Reactivity: Hu Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen Alpha Synuclein
Synonyms Alpha-synuclein; Non-A beta component of AD amyloid; Non-A4 component of amyloid precursor (NACP); NACP; PARK1; SNCA
Location Cytoplasm, Nucleus, Secreted, Synapse
Accession P37840
Clone Number S-6514
Antibody Type Mouse mAb
Isotype IgG1,k
Application IHC-P
Reactivity Hu
Positive Sample Human brain
Purification Protein A
Concentration 2 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
IHC-P 1:250 Hu

Background

α-Synuclein is a small soluble presynaptic protein of 140 amino acids with a molecular weight of approximately 14.5 kDa, encoded by the SNCA gene on human chromosome 4 and highly conserved among vertebrates. Its structure comprises three characteristic domains: an N-terminal lipid-binding domain (containing seven 11-amino-acid repeats that can form amphipathic α-helices), a central hydrophobic NAC region (responsible for fibrillar aggregation), and a negatively charged acidic C-terminal tail. Under physiological conditions, α-synuclein exists predominantly in the cytosol as a natively unfolded monomer, and through electrostatic binding to negatively charged phospholipids on synaptic vesicle membranes it undergoes a transition to an α-helical conformation, participating in the regulation of synaptic vesicle trafficking, clustering, exocytosis, and neurotransmitter release. Under pathological conditions, however, the protein misfolds into a β-sheet-rich structure, oligomerizes, and further forms amyloid fibrils, ultimately depositing within neurons as Lewy bodies—the shared pathological hallmark of "synucleinopathies" such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Notably, approximately 90% of α-synuclein in Lewy bodies is in the Ser129-phosphorylated form; although this modification is also regulated by neuronal activity under normal physiological conditions and participates in the fine-tuning of synaptic function, in the pathological state it becomes a widely recognized surrogate pathological marker due to the accumulation of aggregates. In addition, point mutations in the SNCA gene (such as A53T, A30P, and E46K) as well as gene duplication/triplication can cause familial early-onset Parkinson's disease, further confirming the central role of α-synuclein in the pathogenesis of neurodegenerative diseases.

Picture

Immunohistochemistry

IHC shows positive staining in paraffin-embedded human brain. Anti-Alpha Synuclein antibody was used at 1/250 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Negative control: IHC shows negative staining in paraffin-embedded human kidney. Anti-Alpha Synuclein antibody was used at 1/250 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Negative control: IHC shows negative staining in paraffin-embedded human colon cancer. Anti-Alpha Synuclein antibody was used at 1/250 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.